The DOI matches its Crossref record.
YB‐1 is upregulated during prostate cancer tumor progression and increases P‐glycoprotein activity
Abstract
BACKGROUND: Currently, the main obstacle to curing advanced prostate cancer is development of androgen independence (AI), where malignant cells acquire the ability to survive in the absence of androgens. Our initial experimental approach used cDNA microarrays to characterize changes in gene expression in the LNCaP human prostate tumor model during progression to AI. The transcription factor Y‐box binding protein (YB‐1) was shown to be one of the genes upregulated. We focused on increased YB‐1 expression during progression in clinical specimens, and further examined one of its downstream targets, P‐glycoprotein (P‐gp). METHODS: Northern blot analysis was performed on LNCaP tumor series, as well as immunohistochemical analyses of human prostate cancer tissue samples. YB‐1 was transiently transfected and transport analysis were performed to analyze P‐gp efflux activity. RESULTS: YB‐1 expression is markedly increased during benign to malignant transformation and further following androgen ablation. In addition, increased YB‐1 expression after castration in the LNCaP model is linked to upregulation of P‐gp. We demonstrate that YB‐1 upregulates P‐gp activity resulting in a 40% intracellular decrease in the P‐gp substrate vinblastine. We have also found that P‐gp increases the efflux of the endogenous androgen, dihydrotestosterone (DHT), from prostate cells and leads to decreased androgen regulated gene expression. CONCLUSIONS: We hypothesize that early in prostate cancer progression, increased expression of YB‐1 may increase P‐gp activity which may in turn lower androgen levels in the prostate tumor cells. Suppression of androgen levels may activate cell survival pathways and lead to an adaptive survival advantage of androgen independent prostate cancer cells following androgen ablation therapy. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Locke, J. A., Guns, E. S., Lubik, A. A., Adomat, H. H., Hendy, S. C., Wood, C. A., Ettinger, S. L., Gleave, M. E., & Nelson, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5997 · Cited by 747
Self-citationRNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?
Fabbiano, F., Corsi, J., Gurrieri, E., Trevisan, C., Notarangelo, M., & D'Agostino, V. G. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12043 · Cited by 302
Sutherland, B. W., Kucab, J., Wu, J., Lee, C., Cheang, M. C. U., Yorida, E., Turbin, D., Dedhar, S., Nelson, C., Pollak, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208590 · Cited by 299
Self-citationA molecular correlate to the Gleason grading system for prostate adenocarcinoma
True, L., Coleman, I., Hawley, S., Huang, C.-Y., Gifford, D., Coleman, R., Beer, T. M., Gelmann, E., Datta, M., Mostaghel, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603678103 · Cited by 291
Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis
El-Naggar, A. M., Veinotte, C. J., Cheng, H., Grunewald, T. G. P., Negri, G. L., Somasekharan, S. P., Corkery, D. P., Tirode, F., Mathers, J., Khan, D., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.003 · Cited by 283
Metadata
- Authors
- Giménez‐Bonafé, P., Fedoruk, M. N., Whitmore, T. G., Akbari, M., Ralph, J. L., Ettinger, S., Gleave, M. E., & Nelson, C. C.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2004-01-05
- Volume
- 59
- Issue
- 3
- Pages
- 337-349
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2007951687
- Cited by
- 165
- References
- 0
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: YB‐1 is upregulated during prostate cancer tumor progression and increases P‐glycoprotein activity. https://app.cochat.ai/papers/10.1002/pros.20023
- The paper
- Giménez‐Bonafé, P., Fedoruk, M. N., Whitmore, T. G., Akbari, M., Ralph, J. L., Ettinger, S., Gleave, M. E., & Nelson, C. C. (2004). YB‐1 is upregulated during prostate cancer tumor progression and increases P‐glycoprotein activity. The Prostate. https://doi.org/10.1002/pros.20023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.